152 related articles for article (PubMed ID: 19713605)
21. Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent Levovist.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2004 Feb; 23(2):207-15. PubMed ID: 14992357
[TBL] [Abstract][Full Text] [Related]
22. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].
Bartolotta TV; Sandonato L; Taibbi A; Latteri S; Soresi M; Lombardo G; Genova C; Latteri MA
Chir Ital; 2009; 61(3):295-307. PubMed ID: 19694231
[TBL] [Abstract][Full Text] [Related]
23. [Contrast-enhanced ultrasound in the diagnosis of benign and malignant hepatic tumors].
Jiang Y; Zhou Q; Zhu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):53-6. PubMed ID: 22349380
[TBL] [Abstract][Full Text] [Related]
24. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound.
Clevert DA; Jung EM; Stock KF; Weckbach S; Feuerbach S; Reiser M; Jung F
Z Gastroenterol; 2009 Dec; 47(12):1195-202. PubMed ID: 19960397
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.
Dietrich CF; Schuessler G; Trojan J; Fellbaum C; Ignee A
Br J Radiol; 2005 Aug; 78(932):704-7. PubMed ID: 16046421
[TBL] [Abstract][Full Text] [Related]
27. Utility of contrast-enhanced ultrasound for evaluation of thyroid nodules.
Zhang B; Jiang YX; Liu JB; Yang M; Dai Q; Zhu QL; Gao P
Thyroid; 2010 Jan; 20(1):51-7. PubMed ID: 20067379
[TBL] [Abstract][Full Text] [Related]
28. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis.
Kim SH; Lee JM; Lee JY; Han JK; An SK; Han CJ; Lee KH; Hwang SS; Choi BI
AJR Am J Roentgenol; 2005 Apr; 184(4):1077-84. PubMed ID: 15788576
[TBL] [Abstract][Full Text] [Related]
29. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
30. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.
Wu W; Chen MH; Yin SS; Yan K; Fan ZH; Yang W; Dai Y; Huo L; Li JY
AJR Am J Roentgenol; 2006 Sep; 187(3):752-61. PubMed ID: 16928941
[TBL] [Abstract][Full Text] [Related]
31. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
Jung EM; Clevert DA; Rupp N
Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
[TBL] [Abstract][Full Text] [Related]
32. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of malignant liver tumors by software-based perfusion quantification with dynamic contrast-enhanced ultrasound (DCEUS).
Wildner D; Schellhaas B; Strack D; Goertz RS; Pfeifer L; Fiessler C; Neurath MF; Strobel D
Clin Hemorheol Microcirc; 2019; 71(1):39-51. PubMed ID: 29865043
[TBL] [Abstract][Full Text] [Related]
34. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.
von Herbay A; Vogt C; Häussinger D
J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study.
Jung EM; Clevert DA; Schreyer AG; Schmitt S; Rennert J; Kubale R; Feuerbach S; Jung F
World J Gastroenterol; 2007 Dec; 13(47):6356-64. PubMed ID: 18081224
[TBL] [Abstract][Full Text] [Related]
36. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.
D'Onofrio M; Rozzanigo U; Masinielli BM; Caffarri S; Zogno A; Malagò R; Procacci C
J Clin Ultrasound; 2005 May; 33(4):164-72. PubMed ID: 15856516
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing.
Bleuzen A; Huang C; Olar M; Tchuenbou J; Tranquart F
Ultraschall Med; 2006 Feb; 27(1):40-8. PubMed ID: 16470478
[TBL] [Abstract][Full Text] [Related]
38. Focal liver lesions: sinusoidal phase of CEUS.
D'Onofrio M; Martone E; Faccioli N; Zamboni G; Malagò R; Mucelli RP
Abdom Imaging; 2006; 31(5):529-36. PubMed ID: 16802201
[TBL] [Abstract][Full Text] [Related]
39. Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout.
Bhayana D; Kim TK; Jang HJ; Burns PN; Wilson SR
AJR Am J Roentgenol; 2010 Apr; 194(4):977-83. PubMed ID: 20308500
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced ultrasound of histologically proven liver hemangiomas.
Dietrich CF; Mertens JC; Braden B; Schuessler G; Ott M; Ignee A
Hepatology; 2007 May; 45(5):1139-45. PubMed ID: 17464990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
